SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-003387
Filing Date
2024-01-09
Accepted
2024-01-09 16:49:22
Documents
11
Period of Report
2024-01-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K celu-20240103.htm   iXBRL 8-K 45859
2 EX-99.1 celu-ex99_1.htm EX-99.1 15533
  Complete submission text file 0000950170-24-003387.txt   216353

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT celu-20240103.xsd EX-101.SCH 49803
5 EXTRACTED XBRL INSTANCE DOCUMENT celu-20240103_htm.xml XML 6500
Mailing Address 170 PARK AVE FLORHAM PARK NJ 07932
Business Address 170 PARK AVE FLORHAM PARK NJ 07932 (908) 768-2170
Celularity Inc (Filer) CIK: 0001752828 (see all company filings)

IRS No.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38914 | Film No.: 24523857
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)